ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF19.17

F19.17

Billable

Other psychoactive substance abuse with psychoactive substance-induced persisting dementia

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F19.17 is a billable code used to indicate a diagnosis of other psychoactive substance abuse with psychoactive substance-induced persisting dementia.

Key Diagnostic Point:

F19.17 refers to a condition characterized by the abuse of psychoactive substances that leads to persistent dementia-like symptoms. This diagnosis is applicable when an individual has a history of substance use disorder involving substances not classified under other specific categories, such as alcohol or opioids. The dementia symptoms are a direct result of the neurotoxic effects of the substances used, which can include memory impairment, cognitive dysfunction, and changes in behavior. The condition is often chronic and can significantly impair daily functioning. Treatment typically involves a combination of substance abuse rehabilitation, cognitive therapy, and supportive care to manage symptoms and improve quality of life. It is crucial for healthcare providers to document the history of substance use, the specific substances involved, and the cognitive deficits observed to ensure accurate coding and appropriate treatment planning.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Variety of substances that can lead to similar symptoms
  • Need for comprehensive documentation of substance use history
  • Differentiation from other types of dementia
  • Potential for co-occurring mental health disorders

Audit Risk Factors

  • Inadequate documentation of substance use history
  • Failure to specify the psychoactive substances involved
  • Lack of evidence for cognitive impairment linked to substance use
  • Misclassification of the type of dementia

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Detailed history of substance use, mental status examination, and cognitive assessments.

Common Clinical Scenarios

Patients presenting with cognitive decline and a history of substance abuse.

Billing Considerations

Consideration of co-occurring mental health disorders and the need for a multidisciplinary approach.

Neurology

Documentation Requirements

Neurological evaluations, imaging studies, and cognitive testing results.

Common Clinical Scenarios

Patients with cognitive deficits where substance use history is relevant.

Billing Considerations

Differentiating between substance-induced dementia and other neurodegenerative conditions.

Coding Guidelines

Inclusion Criteria

Use F19.17 When
  • According to ICD
  • 10 coding guidelines, F19
  • 17 should be used when there is clear evidence of substance abuse leading to persistent cognitive impairment
  • Documentation must support the diagnosis, including the type of substances used and the duration of abuse

Exclusion Criteria

Do NOT use F19.17 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

H0031CPT Code

Mental health assessment

Clinical Scenario

Used during initial evaluation of cognitive impairment in substance abusers.

Documentation Requirements

Comprehensive assessment results and treatment plan.

Specialty Considerations

Psychiatric evaluation may require additional documentation of substance use history.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of substance-related disorders, improving the ability to capture the complexity of conditions like F19.17. This specificity aids in better treatment planning and resource allocation.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of substance-related disorders, improving the ability to capture the complexity of conditions like F19.17. This specificity aids in better treatment planning and resource allocation.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of substance-related disorders, improving the ability to capture the complexity of conditions like F19.17. This specificity aids in better treatment planning and resource allocation.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between F19.17 and F19.10?

F19.17 includes the additional complexity of persistent dementia symptoms resulting from substance abuse, while F19.10 refers to uncomplicated psychoactive substance abuse without cognitive impairment.